(Q36577861)

15 August 2017

1 reference

title

Metabolic monitoring for patients treated with antipsychotic medications (English)

1 reference

15 August 2017

Tony A Cohn

1

1 reference

15 August 2017

Michael J Sernyak

series ordinal

2

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 July 2006

1 reference

Canadian Journal of Psychiatry

15 August 2017

published in

1 reference

15 August 2017

volume

51

1 reference

15 August 2017

issue

8

1 reference

15 August 2017

page(s)

492-501

1 reference

Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100804

Mortality and causes of death in schizophrenia in Stockholm county, Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100804

Excess mortality of schizophrenia. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100804

Characterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100804

A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100804

Quality of preventive medical care for patients with mental disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100804

Schizophrenia and increased risks of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100804

Disparities in diabetes care: impact of mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100804

Prevention of Type 2 diabetes mellitus. A review of the evidence and its application in a UK setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100804

Diabetes mellitus and impaired glucose tolerance in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100804

Screening for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100804

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100804

Prediction of Coronary Heart Disease Using Risk Factor Categories

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100804

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100804

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100804

Atypical antipsychotics and glucose dysregulation: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100804

Association between antipsychotic drugs and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100804

Physical health monitoring of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100804

Consensus development conference on antipsychotic drugs and obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100804

Belgian consensus on metabolic problems associated with atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100804

10.1177/070674370605100804

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference